(Q33332939)
Statements
A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma (English)
D F McDermott
J W Mier
D P Lawrence
M R van den Brink
M A Clancy
K M Rubin